113 related articles for article (PubMed ID: 11892910)
1. THF carbapenems. Wyeth Ayerst.
Jiraskova N
Curr Opin Investig Drugs; 2001 Aug; 2(8):1035-8. PubMed ID: 11892910
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in-vitro activity of novel 1beta-methylcarbapenems having spiro[2,4]heptane moieties.
Park HB; Jo NH; Hong JH; Choi JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2007 Oct; 340(10):530-7. PubMed ID: 17849445
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
[TBL] [Abstract][Full Text] [Related]
4. Carbapenems: a potent class of antibiotics.
Nicolau DP
Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
6. Newer carbapenems for urinary tract infections.
Matsumoto T; Muratani T
Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S35-8. PubMed ID: 15364304
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
Oh CH; Lee CS; Lee JS; Cho JH
Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolidinopyrrolidin-3-ylthio)carbapenems and related compounds.
Oh CH; Cho HW; Lee IK; Gong JY; Choi JH; Cho JH
Arch Pharm (Weinheim); 2002 Apr; 335(4):152-8. PubMed ID: 12112035
[TBL] [Abstract][Full Text] [Related]
9. Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems.
Hakimelahi GH; Moosavi-Movahedi AA; Saboury AA; Osetrov V; Khodarahmi GA; Shia KS
Eur J Med Chem; 2005 Apr; 40(4):339-49. PubMed ID: 15804533
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 1beta-methylcarbapenems having cyclic thiourea moieties and their related compounds.
Han T; Cho JH; Oh CH
Eur J Med Chem; 2006 Jul; 41(7):825-32. PubMed ID: 16737759
[TBL] [Abstract][Full Text] [Related]
11. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in vitro antibacterial activity.
Kim SJ; Park HB; Lee JS; Jo NH; Yoo KH; Baek D; Kang BW; Cho JH; Oh CH
Eur J Med Chem; 2007 Sep; 42(9):1176-83. PubMed ID: 17418453
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K
Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems.
Weiss WJ; Petersen PJ; Jacobus NV; Lin YI; Bitha P; Testa RT
Antimicrob Agents Chemother; 1999 Mar; 43(3):454-9. PubMed ID: 10049250
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activities of 4-pyrrolidinylthio carbapenems: containing heteroaromatics as a side chain.
Cho HW; Oh CH; Lee JS; Lee SC; Choi JH; Cho JH
Arch Pharm (Weinheim); 2003 Nov; 336(11):495-503. PubMed ID: 14639741
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of 1beta-methylcarbapenems having a 2, 2-disubstituted-1, 3-diazabicyclo[3.3.0]octan-4-one moiety and related compounds. Part III.
Oh CH; Dong HG; Cho HW; Park SJ; Hong JH; Baek D; Cho JH
Arch Pharm (Weinheim); 2002 May; 335(5):200-6. PubMed ID: 12210776
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial evaluation of 1beta-methyl-2-[5-(1-methoxyimino-2-substituted sulfonamide ethyl)pyrrolidin-3-ylthio]carbapenems and their related compounds.
Jeon H; Jo NH; Yoo KH; Choi JH; Cho H; Cho JH; Oh CH
Eur J Med Chem; 2007 Mar; 42(3):358-64. PubMed ID: 17156896
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in-vitro activity of new 1beta-methylcarbapenem derivatives as antibacterial agents.
Jung MH; Hong JH; Cho JH; Oh CH
Arch Pharm (Weinheim); 2008 Dec; 341(12):780-6. PubMed ID: 19009543
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial evaluation of 1beta-methyl-2-(5-substituted heterocyclic carbamoyl)pyrrolidin-3-ylthio)carbapenem derivatives.
Lee JS; Choa JH; Cho H; Oh CH
Arch Pharm (Weinheim); 2004 Jul; 337(7):391-7. PubMed ID: 15237389
[TBL] [Abstract][Full Text] [Related]
20. Carbapenems in the USA: focus on doripenem.
Lister PD
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):793-809. PubMed ID: 17914914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
